Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Study finds hospitals without highest stroke care designation may miss strokes after TAVR
, /in E-News /by panglobalA Michigan Medicine study [1] suggests that hospitals without the highest stroke care designation may be missing strokes that occur after a common heart valve replacement procedure.
Excessive screen time linked to higher risk of OCD in preteens
, /in E-News /by panglobalDuring the holidays, kids often spend more time on screens, leaving parents to wonder: Is it causing harm? Possibly.
Pradel Research Award
, /in E-News /by panglobalAllen Institute’s Hongkui Zeng receives prestigious Pradel Research Award from National Academy of Sciences for pioneering work in neuroscience
OHE Policy Innovation Prize
, /in E-News /by panglobalProf. Aidan Hollis wins first £40,000 OHE Policy Innovation Prize to devise a globally applicable approach to fair pricing of medicines
MDimune to collaborate with Hanyang University on projects selected through the 3rd BioDrone Award
, /in E-News /by panglobalMDimune, a Korean biotech company developing BioDrone platform technology based on cell-derived vesicles (CDVs), has received funding for two research projects focusing on next-generation drug delivery and novel therapeutics. The projects were selected through the 3rd BioDrone Award held in October 2022. For these projects, MDimune signed an MoU with Hanyang University to collaborate with […]
Pfizer expands ‘An Accord for a Healthier World’ product offering to include full portfolio of medicines
, /in E-News /by panglobalPfizer has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccines for which it has global rights on a not-for-profit basis to enable greater health for 1.2 billion people living in 45 lower-income countries.
FORUM LABO PARIS
, /in Advertenties /by panglobalTHE LABORATORY INDUSTRY EXHIBITION DEDICADED TO RESEARCH, PRODUCTION AND CONTROL
NATIONAL HEALTHCARE CFO SUMMIT
, /in Advertenties /by panglobal21-23 MAY 2023
EUROPEAN CONGRESS OF RADIOLOGY ECR 2023
, /in Advertenties /by panglobalCuviva receives MDR certification – paves the way for international growth
, /in Product News /by panglobalThe Cuviva RPM Platform is now certified according to MDR Class IIa. This makes Cuviva RPM Platform one of the first complete platforms certified according to MDR Class IIa for Remote Patient Monitoring and Hospital at Home. The certification demonstrates increased patient safety and efficiency of healthcare, and opens up for further extensive development.